A research team led by Jared Churko, PhD, director of the University of Arizona iPSC Core in the UA Sarver Heart Center, used a transcriptomic approach – studying what genes are expressed – to identify gene signatures of cell subpopulations identified as atrial-like or ventricular-like. This understanding could lead to regenerative therapy discoveries for the millions of people living with damaged heart muscle caused by heart attacks or other chronic heart conditions. Continue reading
Author Archive: AZBio
UA Researcher Awarded $3 Million to Study Genomics in Cerebral Palsy
Michael Kruer, MD, receives the first federally funded grant to research genetic causes of condition that affects 1 in 250 children.Continue reading
ASU researchers awarded $5.8M NIH grant to develop antimicrobial susceptibility test
Resistant strains of bacteria pose a serious threat to the security of our global health system. As more and more bacteria develop resistance to our best antibiotics, once treatable diseases may re-emerge, potentially causing mass epidemics.Continue reading
UA Researchers Help Discover Genetic Factor That Can Help or Hurt Risk for Heart Disease
Individuals with a particular genetic factor may be more resistant to plaque build-up and have a reduced risk for coronary artery disease.Continue reading
Mutations boost immunity: toward a cancer vaccine
In a new study, Stephen Albert Johnston and his colleagues describe a method for pinpointing tumor-specific factors in blood that can elicit a protective immune response in the body and may one day be harnessed to produce an effective vaccine against the disease.Continue reading
EndoVantage and Siemens Healthineers Partner to Bring Endovascular Pretreatment Planning to Hospitals
Partnership with Siemens Healthineers will expand availability of EndoVantage SurgicalPreview® pretreatment planning technologyContinue reading
Invest Southwest Opens Applications for Venture Madness on Dec 14th
Invest Southwest announced the call for applications for the 2019 Venture Madness Conference will begin December 14, 2018 and run through January 10, 2019. Companies gaining market traction are encouraged to apply to compete as one of 24-36 entrants who will live-pitch their unique value for a chance to win a portion of the $60,000 cash prizes, mentorship from seasoned entrepreneurs, executives and investors and exclusive access to active institutional and angel investor judges and attendees from throughout the Southwest.Continue reading
TGen liquid biopsy study seeks to improve monitoring for DIPG
‘See the Change’ study could help future treatment of rare brain cancers in childrenContinue reading